##fileformat=VCFv4.0
##fileDate=20141105
##source=Atlas-SNP2 v1.4.3 r171
##command="/Atlas-SNP2.rb -i input-0.bam -r ref.0.fa -o output-0 -n 1012_realigned_2.txt.dedup.recaled --Illumina -F"
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype Quality">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=RR,Number=1,Type=Integer,Description="Reference Read Depth">
##FORMAT=<ID=VR,Number=1,Type=Integer,Description="Major Variant Read Depth">
##FILTER=<ID=low_snpqual,Description="SNP posterior probability lower than 0.95">
##FILTER=<ID=low_VariantReads,Description="Number of variant reads is less than 3">
##FILTER=<ID=low_VariantRatio,Description="Variant read ratio is less than 0.1">
##FILTER=<ID=single_strand,Description="All variant reads are in a single strand direction">
##FILTER=<ID=low_coverage,Description="Total coverage is less than 6">
##FILTER=<ID=high_coverage,Description="Total coverage is more than 1024">
##FILTER=<ID=No_data,Description="No valid reads on this site">
##FILTER=<ID=No_var,Description="No valid variant read on this site">
##META: Cassandra_version=13.10.01
##META: Annovar-refGene(hg19).Version=2013-07-28
##META: Annovar-knownGene(hg19).Version=2013-07-28
##META: Annovar-ensgene(hg19).Version=2013-07-28
##META: Annovar-ensgene(GRCh37_MT).Version=2013-07-28
##META: DbSNP.Description=NCBIs SNP database.Downloaded=2013-09-27. URL = ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/VCF/00-All.vcf.gz,ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/VCF/00-All.vcf.gz.tbi
##META: HgmdAll.Database_version=01/12/12.Description=Downloaded from HGMD..Downloaded=Dec 01 2012
##META: ESP5400.Description=The current EVS data release (ESP6500SI-V2) is taken from 6503 samples drawn from multiple ESP cohorts and represents all of the ESP exome variant data..Downloaded=2013-09-27. URL = http://evs.gs.washington.edu/evs_bulk_data/ESP6500SI-V2-SSA137.dbSNP138-rsIDs.snps_indels.vcf.tar.gz
##META: CgMaf.Description=Complete genomics variations from the reference genome identified across 54-genome subset of the 69 CG public genomes..Downloaded=2013-09-27. URL = ftp://ftp2.completegenomics.com/Feb2011_Release/CGA_Tools_Output/Public_Genomes_Unrelated_54-listvariants-Freq.bz2
##META: ESEIndel .Database_version=Proprietary.Description=NA.Downloaded=NA
##META: Mappability.Description=Encode 100bp alignability track.Downloaded=2013-09-27. URL = http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/wgEncodeCrgMapabilityAlign100mer.bigWig
##META: 1000 Genomes Phase 1.Description=SNPs Indels and SVs friom 1000 Genomes.Downloaded=2013-09-27. URL = ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/analysis_results/integrated_call_sets/ALL.wgs.integrated_phase1_v3.20101123.snps_indels_sv.sites.vcf.gz,ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/analysis_results/integrated_call_sets/ALL.wgs.integrated_phase1_v3.20101123.snps_indels_sv.sites.vcf.gz.tbi
##META: Swissprot.Description=Uniprot gene annotation.Downloaded=2013-09-27. URL = ftp://ftp.ebi.ac.uk/pub/databases/uniprot/current_release/knowledgebase/taxonomic_divisions/uniprot_sprot_human.dat.gz
##META: Cosmic.Description=Cosmic annotated coding variants.Downloaded=2013-09-30. URL = ftp://ngs.sanger.ac.uk/production/cosmic/CosmicCodingMuts_v66_20130725.vcf.gz
##META: DbNSFP.Description=The dbNSFP is an integrated database of functional annotations from multiple sources for the comprehensive collection of human non-synonymous SNPs.Downloaded=2013-09-27. URL = http://dbnsfp.houstonbioinformatics.org/dbNSFPzip/dbNSFP2.0b4.zip
##META: Encode.Description=Reglatory features from Encode.Downloaded=2013-09-27. URL = ftp://ftp.ensembl.org/pub/release-73/regulation/homo_sapiens/AnnotatedFeatures.gff.gz
##META: Cosmic.Description=Cosmic annotated non-coding variants.Downloaded=2013-09-30. URL = ftp://ngs.sanger.ac.uk/production/cosmic/CosmicNonCodingVariants_v66_20130725.vcf.gz
##INFO=<ID=AC,Number=.,Type=Integer,Description="Allele count in genotypes">
##INFO=<ID=AF,Number=.,Type=Float,Description="Allele frequency">
##INFO=<ID=ReqIncl,Number=.,Type=String,Description="Site was required to be included in the VCF">
##INFO=<ID=PU,Number=.,Type=String,Description="Pileup data. NB:for compliance with the VCF standard ; has been replaced with : (59-58)">
##INFO=<ID=RFG,Number=.,Type=String,Description="Mutation type (Refseq)">
##INFO=<ID=GI,Number=.,Type=String,Description="Proximal gene information (for noncoding variants)">
##INFO=<ID=UCG,Number=.,Type=String,Description="Mutation type (UCSC)">
##INFO=<ID=ENS,Number=.,Type=String,Description="Mutation type (Ensembl)">
##INFO=<ID=ENSGN,Number=1,Type=String,Description="Ensembl gene name">
##INFO=<ID=MT,Number=.,Type=String,Description="Mitochondrial mutation type (Ensembl)">
##INFO=<ID=MTGN,Number=1,Type=String,Description="Mitochondrial gene name">
##INFO=<ID=GN,Number=.,Type=String,Description="Gene name">
##INFO=<ID=RSID,Number=.,Type=String,Description="DBSNP rsid">
##INFO=<ID=CD,Number=.,Type=String,Description="DBSNP Variant Clinical Significance, 0 - unknown, 1 - untested, 2 - non-pathogenic, 3 - probable-non-pathogenic, 4 - probable-pathogenic, 5 - pathogenic, 6 - drug-response, 7 - histocompatibility, 255 - other">
##INFO=<ID=HT,Number=1,Type=String,Description="HGMD mutation type">
##INFO=<ID=HC,Number=1,Type=String,Description="HGMD variant class">
##INFO=<ID=HD,Number=.,Type=String,Description="HGMD disease">
##INFO=<ID=HP,Number=1,Type=String,Description="HGMD pubmed ID">
##INFO=<ID=AV,Number=1,Type=String,Description="ESP6500 variant count in african americans">
##INFO=<ID=AT,Number=1,Type=String,Description="ESP6500 reference count in african americans">
##INFO=<ID=EV,Number=1,Type=String,Description="ESP6500 variant count in europeans">
##INFO=<ID=ET,Number=1,Type=String,Description="ESP6500 reference count in europeans">
##INFO=<ID=CG,Number=1,Type=String,Description="Complete Genomcs MAF">
##INFO=<ID=IET,Number=1,Type=String,Description="ESE indel-count from TCGA">
##INFO=<ID=IEO,Number=1,Type=String,Description="ESE indel-count from non-TCGA">
##INFO=<ID=IEN,Number=.,Type=String,Description="Near-by indels in ESE">
##INFO=<ID=MS,Number=1,Type=String,Description="100mer mapping score">
##INFO=<ID=TMAF,Number=1,Type=String,Description="Thousand Genomes Allele frequency">
##INFO=<ID=TAMR,Number=1,Type=String,Description="Thousand Genomes AMR AF">
##INFO=<ID=TASN,Number=1,Type=String,Description="Thousand Genomes ASN AF">
##INFO=<ID=TAFR,Number=1,Type=String,Description="Thousand Genomes AFR AF">
##INFO=<ID=TEUR,Number=1,Type=String,Description="Thousand Genomes EUR AF">
##INFO=<ID=SF,Number=.,Type=String,Description="Swiss prot function">
##INFO=<ID=SD,Number=.,Type=String,Description="Swiss prot disease association">
##INFO=<ID=SM,Number=.,Type=String,Description="Swiss prot post translational modifications">
##INFO=<ID=SX,Number=.,Type=String,Description="Swiss prot expression">
##INFO=<ID=CID,Number=1,Type=String,Description="Cosmic ID">
##INFO=<ID=CGENE,Number=1,Type=String,Description="Cosmic gene name">
##INFO=<ID=CSTRAND,Number=1,Type=String,Description="Cosmic gene strand">
##INFO=<ID=CCDS,Number=1,Type=String,Description="Cosmic CDS annotation">
##INFO=<ID=CAA,Number=1,Type=String,Description="Cosmic peptide annotation">
##INFO=<ID=CCNT,Number=1,Type=String,Description="How many Cosmic samples have this mutation">
##INFO=<ID=NA,Number=.,Type=String,Description="nsdb PhyloP score, the larger the score, the more conserved the site.">
##INFO=<ID=NC,Number=.,Type=String,Description="nsdb SIFT score, If a score is smaller than 0.05 the corresponding NS is predicted as 'D(amaging)' otherwise it is predicted as 'T(olerated)'">
##INFO=<ID=NE,Number=.,Type=String,Description="nsdb Polyphen2_HVAR_score: Polyphen2 score based on HumVar, i.e. hvar_prob.The score ranges from 0 to 1, and the corresponding prediction is 'probably damaging' if it is in [0.909,1]; 'possibly damaging' if it is in [0.447,0.908]; 'benign' if it is in [0,0.446]. Score cutoff for binary classification is 0.5, i.e. the prediction is 'neutral' if the score is smaller than 0.5 and 'deleterious' if the score is larger than 0.5. Multiple entries separated by ';'.">
##INFO=<ID=NF,Number=.,Type=String,Description="nsdb Polyphen2_HVAR_pred: Polyphen2 prediction based on HumVar, 'D' ('porobably damaging'),'P' ('possibly damaging') and 'B' ('benign'). Multiple entries separated by ';'.">
##INFO=<ID=NG,Number=.,Type=String,Description="nsdb LRT score">
##INFO=<ID=NH,Number=.,Type=String,Description="nsdb LRT prediction, D(eleterious), N(eutral) or U(nknown)">
##INFO=<ID=NI,Number=.,Type=String,Description="nsdb Mut tatser score">
##INFO=<ID=NJ,Number=.,Type=String,Description="nsdb MutationTaster prediction, 'A' ('disease_causing_automatic'),'D' ('disease_causing'), 'N' ('polymorphism') or 'P' ('polymorphism_automatic')">
##INFO=<ID=NK,Number=.,Type=String,Description="nsdb MutationAssessor functional impact combined score">
##INFO=<ID=NL,Number=.,Type=String,Description="nsdb MutationAssessor 'functional impact of a variant : predicted functional (high, medium), predicted non-functional (low, neutral)' Please refer to Reva et al. Nucl. Acids Res. (2011) 39(17):e118 for details">
##INFO=<ID=NM,Number=.,Type=String,Description="nsdb Interpro_domain: domain or conserved site on which the variant locates. Domain annotations come from Interpro database. The number in the brackets following a specific domain is the count of times Interpro assigns the variant position to that domain, typically coming from different predicting databases. Multiple entries separated by ';'.">
##INFO=<ID=ENN,Number=1,Type=String,Description="Encode Name">
##INFO=<ID=ENC,Number=1,Type=String,Description="Encode class">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	1012_realigned_2.txt.dedup.recaled
1	14590	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.2;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:6:8:14:.
1	14599	.	T	A	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.2;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:8:9:17:.
1	14604	.	A	G	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.333333;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:9:12:21:.
1	14610	.	T	C	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.2;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:11:17:28:.
1	14653	.	C	T	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs375086259;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.25;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:40:34:74:.
1	14741	.	C	A	2	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=WASH7P,NONE(dist=NONE),NONE(dist=NONE),ENSG00000227232;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.125;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:2:304:306:.
1	14907	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs79585140;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:51:93:144:.
1	14930	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs75454623;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:62:97:159:.
1	14932	.	G	T	59	single_strand;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:3:156:159:.
1	15211	.	T	G	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs78601809;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.125;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:8:2:10:.
1	16378	.	T	C	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=WASH7P,ENSG00000227232,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000227232;MT=intergenic;MTGN=.;GN=WASH7P;RSID=rs148220436;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,CTCF;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	565286	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=OR4F29(dist=196689),OR4F29(dist=55810),ENSG00000225630,NONE(dist=NONE),NONE(dist=NONE),JA429830,JA429831,JB137814;UCG=downstream;ENS=ncRNA_exonic;ENSGN=ENSG00000225630;MT=intergenic;MTGN=.;GN=OR4F29(dist=196689);RSID=rs1578391;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=COSN204013;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=.;ENC=.	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	565374	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=OR4F29(dist=196777),OR4F29(dist=55722),ENSG00000225630,NONE(dist=NONE),NONE(dist=NONE),JA429830,JA429831,JB137814;UCG=downstream;ENS=ncRNA_exonic;ENSGN=ENSG00000225630;MT=intergenic;MTGN=.;GN=OR4F29(dist=196777);RSID=rs9701779;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=.;ENC=.	GT:VR:RR:DP:GQ	0/1:6:1:7:.
1	745347	.	T	C	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC100288069(dist=31279),FAM87B(dist=7404),NONE(dist=NONE),NONE(dist=NONE),ENSG00000237491,LOC100288069(dist=31279),LINC00115(dist=16239);UCG=intergenic;ENS=ncRNA_exonic;ENSGN=ENSG00000237491;MT=intergenic;MTGN=.;GN=.;RSID=rs373594198;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.333333;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:6:24:30:.
1	762086	.	C	A	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880,LINC00115:uc010nxx.2:exon1:c.G486T:p.K162N,;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H2BK5ac,H3K36ac,DNase1,E2F6,H4K91ac;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:4:763:767:.
1	762201	.	T	C	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,ENSG00000225880,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.A371G:p.E124G,;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:3:319:322:.
1	762273	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,ENSG00000225880,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.C299T:p.P100L,;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs3115849;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.80;TASN=0.86;TAFR=0.33;TEUR=0.84;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:145:3:148:.
1	762330	.	G	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,ENSG00000225880,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.C242A:p.P81Q,;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs74045217;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.05;TAMR=0.02;TASN=0.01;TAFR=0.18;TEUR=0.02;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:23:204:227:.
1	762345	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,ENSG00000225880,NONE(dist=NONE),NONE(dist=NONE),LINC00115:uc010nxx.2:exon1:c.T227C:p.L76P,;UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs74045218;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.06;TAMR=0.03;TASN=0.01;TAFR=0.21;TEUR=0.02;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:34:213:247:.
1	762442	.	C	T	59	low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,LINC00115:uc010nxx.2:exon1:c.G130A:p.A44T,,ENSG00000225880,NONE(dist=NONE),NONE(dist=NONE);UCG=nonsynonymous_SNV;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4me2,H3K4ac,H3K27ac,H3K79me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,H4K5ac,Max,CTCF,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,Cmyc,ELF1;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:5:616:621:.
1	762589	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs71507461;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.73;TAMR=0.78;TASN=0.83;TAFR=0.44;TEUR=0.82;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:117:5:122:.
1	762592	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs71507462;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.78;TASN=0.83;TAFR=0.43;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:107:4:111:.
1	762601	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs71507463;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.77;TASN=0.83;TAFR=0.43;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:106:4:110:.
1	762632	.	T	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=rs61768173;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.72;TAMR=0.78;TASN=0.82;TAFR=0.44;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,H4K8ac,Gabp,H4K5ac,Cmyc,ELF1,H2AK9ac,Tr4,Tcf12,TAF1,HEY1,Yy1,Pbx3;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:120:3:123:.
1	762877	.	G	A	2	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LINC00115,NONE(dist=NONE),NONE(dist=NONE),ENSG00000225880;UCG=UTR5;ENS=ncRNA_exonic;ENSGN=ENSG00000225880;MT=intergenic;MTGN=.;GN=LINC00115;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K9ac,H3K4me3,H3K27me3,H3K4ac,H3K27ac,H3K4me2,H3K18ac,PolII,H2BK120ac,H2BK20ac,H3K36ac,DNase1,E2F6,H4K91ac,Max,H2AZ,Sin3Ak20,H2BK5ac,Gabp,Cmyc,ELF1,Tr4,Tcf12,TAF1,HEY1,Yy1,CBP,E2F4,HNF4A,ZBTB7A;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:2:121:123:.
1	771823	.	T	C	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=LOC643837,NONE(dist=NONE),NONE(dist=NONE),ENSG00000228794;UCG=ncRNA_intronic;ENS=ncRNA_intronic;ENSGN=ENSG00000228794;MT=intergenic;MTGN=.;GN=LOC643837;RSID=rs2977605;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.84;TASN=0.88;TAFR=0.48;TEUR=0.87;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	778569	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=LOC643837,NONE(dist=NONE),NONE(dist=NONE),ENSG00000228794;UCG=ncRNA_exonic;ENS=ncRNA_intronic;ENSGN=ENSG00000228794;MT=intergenic;MTGN=.;GN=LOC643837;RSID=rs2977615;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.99;TAMR=0.99;TASN=1.00;TAFR=0.95;TEUR=1.00;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K4me1,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	785989	.	T	C	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=LOC643837,ENSG00000228794,NONE(dist=NONE),NONE(dist=NONE);UCG=ncRNA_intronic;ENS=ncRNA_intronic;ENSGN=ENSG00000228794;MT=intergenic;MTGN=.;GN=LOC643837;RSID=rs2980300;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.64;TAMR=0.74;TASN=0.70;TAFR=0.17;TEUR=0.85;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1,CTCF;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	796534	.	T	C	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC643837(dist=1708),FAM41C(dist=6917),NONE(dist=NONE),NONE(dist=NONE),ENSG00000228794(dist=1708),ENSG00000230368(dist=6917);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs72631879;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,HNF4A;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	798026	.	C	T	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC643837(dist=3200),FAM41C(dist=5425),NONE(dist=NONE),NONE(dist=NONE),ENSG00000228794(dist=3200),ENSG00000230368(dist=5425);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs4951864;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.86;TAMR=0.90;TASN=0.89;TAFR=0.76;TEUR=0.88;SF=.;SD=.;SM=.;SX=.;CID=COSN407433;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	802191	.	G	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC643837(dist=7365),FAM41C(dist=1260),ENSG00000228794(dist=7365),ENSG00000230368(dist=1260),NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs71507475;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,Znf263,USF1;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:3:2:5:.
1	802222	.	G	A	2	low_snpqual;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC643837(dist=7396),FAM41C(dist=1229),NONE(dist=NONE),NONE(dist=NONE),ENSG00000228794(dist=7396),ENSG00000230368(dist=1229);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs10793769;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,Znf263,USF1;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:2:4:6:.
1	808631	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000230368;UCG=ncRNA_intronic;ENS=ncRNA_intronic;ENSGN=ENSG00000230368;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs11240779;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.50;TAMR=0.68;TASN=0.38;TAFR=0.09;TEUR=0.77;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,CTCF;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:24:0:24:.
1	808922	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000234711;UCG=ncRNA_intronic;ENS=ncRNA_exonic;ENSGN=ENSG00000234711;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs6594027;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.85;TAMR=0.90;TASN=0.87;TAFR=0.79;TEUR=0.86;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:34:0:34:.
1	808928	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=FAM41C,NONE(dist=NONE),NONE(dist=NONE),ENSG00000234711;UCG=ncRNA_intronic;ENS=ncRNA_exonic;ENSGN=ENSG00000234711;MT=intergenic;MTGN=.;GN=FAM41C;RSID=rs11240780;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.5;TMAF=0.46;TAMR=0.65;TASN=0.37;TAFR=0.09;TEUR=0.69;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:27:0:27:.
1	814244	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=2062),LOC100130417(dist=38709),ENSG00000230368(dist=1961),ENSG00000269308(dist=3799),NONE(dist=NONE),NONE(dist=NONE),FAM41C(dist=2062),AK056486(dist=32571);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs185093448;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.333333;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	814297	.	T	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=2115),LOC100130417(dist=38656),NONE(dist=NONE),NONE(dist=NONE),ENSG00000230368(dist=2014),ENSG00000269308(dist=3746),FAM41C(dist=2115),AK056486(dist=32518);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs72888851;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	814300	.	T	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=2118),LOC100130417(dist=38653),ENSG00000230368(dist=2017),ENSG00000269308(dist=3743),NONE(dist=NONE),NONE(dist=NONE),FAM41C(dist=2118),AK056486(dist=32515);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs80022136;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	835499	.	A	G	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=23317),LOC100130417(dist=17454),NONE(dist=NONE),NONE(dist=NONE),ENSG00000269308(dist=15516),ENSG00000230699(dist=11316),FAM41C(dist=23317),AK056486(dist=11316);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs4422948;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.29;TAMR=0.23;TASN=0.21;TAFR=0.47;TEUR=0.25;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:2:6:.
1	842362	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=30180),LOC100130417(dist=10591),NONE(dist=NONE),NONE(dist=NONE),ENSG00000269308(dist=22379),ENSG00000230699(dist=4453),FAM41C(dist=30180),AK056486(dist=4453);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs28540380;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.21;TAMR=0.21;TASN=0.15;TAFR=0.24;TEUR=0.23;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,PU1;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:4:1:5:.
1	847491	.	G	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=35309),LOC100130417(dist=5462),ENSG00000230699,NONE(dist=NONE),NONE(dist=NONE),AK056486;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000230699;MT=intergenic;MTGN=.;GN=FAM41C(dist=35309);RSID=rs28407778;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.23;TAMR=0.27;TASN=0.10;TAFR=0.37;TEUR=0.20;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,Nrsf;ENC=Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	848738	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=36556),LOC100130417(dist=4215),ENSG00000230699,NONE(dist=NONE),NONE(dist=NONE),AK056486;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000230699;MT=intergenic;MTGN=.;GN=FAM41C(dist=36556);RSID=rs3829741;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.16;TAMR=0.23;TASN=0.10;TAFR=0.10;TEUR=0.20;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	849998	.	A	G	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=37816),LOC100130417(dist=2955),ENSG00000230699,NONE(dist=NONE),NONE(dist=NONE),AK056486;UCG=ncRNA_exonic;ENS=ncRNA_exonic;ENSGN=ENSG00000230699;MT=intergenic;MTGN=.;GN=FAM41C(dist=37816);RSID=rs13303222;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.86;TASN=0.77;TAFR=0.83;TEUR=0.81;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	851190	.	G	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=39008),LOC100130417(dist=1763),NONE(dist=NONE),NONE(dist=NONE),ENSG00000230699,ENSG00000241180,AK056486;UCG=downstream;ENS=downstream;ENSGN=ENSG00000230699;MT=intergenic;MTGN=.;GN=FAM41C(dist=39008);RSID=rs28609852;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.22;TAMR=0.28;TASN=0.10;TAFR=0.34;TEUR=0.20;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	851204	.	G	C	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=39022),LOC100130417(dist=1749),NONE(dist=NONE),NONE(dist=NONE),ENSG00000230699,ENSG00000241180,AK056486;UCG=downstream;ENS=downstream;ENSGN=ENSG00000230699;MT=intergenic;MTGN=.;GN=FAM41C(dist=39022);RSID=rs28552953;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.24;TAMR=0.28;TASN=0.10;TAFR=0.41;TEUR=0.21;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	851757	.	A	G	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=FAM41C(dist=39575),LOC100130417(dist=1196),NONE(dist=NONE),NONE(dist=NONE),ENSG00000223764,AK056486(dist=1429),LOC100130417(dist=1196);UCG=intergenic;ENS=downstream;ENSGN=ENSG00000223764;MT=intergenic;MTGN=.;GN=.;RSID=rs4970464;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=0.99;TEUR=1.00;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	856476	.	A	G	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=LOC100130417(dist=1659),SAMD11(dist=4645),NONE(dist=NONE),NONE(dist=NONE),ENSG00000223764(dist=1404),ENSG00000187634(dist=3784),LOC100130417(dist=1659),SAMD11(dist=4054);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs4040605;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.48;TAMR=0.50;TASN=0.45;TAFR=0.70;TEUR=0.37;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,Ap2alpha,Ap2gamma,ZBTB7A,CTCF,CTCFL,Max,Cmyc,Rad21;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	861808	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000268179;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs13302982;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.69;TAMR=0.84;TASN=0.52;TAFR=0.36;TEUR=0.97;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,H3K4me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	862093	.	T	C	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,ENSG00000268179,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs13303291;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.69;TAMR=0.84;TASN=0.52;TAFR=0.35;TEUR=0.97;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	864726	.	T	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000268179;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs2340590;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=1.00;TAFR=0.83;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	864755	.	A	G	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,ENSG00000268179,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs2340589;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.80;TAMR=0.86;TASN=0.85;TAFR=0.40;TEUR=0.99;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	864757	.	G	A	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000268179;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs2340588;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.77;TAMR=0.83;TASN=0.81;TAFR=0.39;TEUR=0.95;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	864938	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,ENSG00000268179,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs2340587;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.54;TAMR=0.62;TASN=0.45;TAFR=0.23;TEUR=0.75;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:8:2:10:.
1	866319	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000268179;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs9988021;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=1.00;TAFR=0.83;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:47:0:47:.
1	866920	.	A	G	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs2341361;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=1.00;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	868329	.	A	C	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs2341359;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.97;TAMR=0.99;TASN=1.00;TAFR=0.89;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	868418	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs28546443;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.19;TAMR=0.28;TASN=0.08;TAFR=0.06;TEUR=0.31;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	868791	.	C	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs13303003;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.93;TASN=1.00;TAFR=0.70;TEUR=0.97;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	870903	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs13303094;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.99;TASN=1.00;TAFR=0.82;TEUR=1.00;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,H3K4me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:15:0:15:.
1	871334	.	G	T	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs4072383;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.51;TAMR=0.61;TASN=0.46;TAFR=0.19;TEUR=0.70;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:15:21:36:.
1	874314	.	G	A	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs117605689;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.01;TAMR=0.04;TASN=0.0035;TAFR=.;TEUR=.;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:9:10:19:.
1	876499	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=SAMD11,ENSG00000187634,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs4372192;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3853;AT=509;EV=8004;ET=532;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.92;TASN=0.92;TAFR=0.86;TEUR=0.95;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H3K4me3,H3K4me2,H3K9ac,H4K20me1,H3K4me1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:114:0:114:.
1	878314	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=SAMD11:NM_152486:exon11:c.G1440C:p.G480G,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634:ENST00000342066:exon11:c.G1440C:p.G480G,,SAMD11:uc001abw.1:exon11:c.G1440C:p.G480G,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=SAMD11;RSID=rs142558220;CD=.;HT=.;HC=.;HD=.;HP=.;AV=56;AT=4108;EV=550;ET=7674;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.05;TAMR=0.06;TASN=.;TAFR=0.01;TEUR=0.10;SF=May_play_a_role_in_photoreceptor_development_(By_similarity).;SD=.;SM=.;SX=.;CID=COSM426784;CGENE=SAMD11;CSTRAND=+;CCDS=c.1440G>C;CAA=p.G480G;CCNT=1;NA=-0.159000;NC=0.340000;NE=.;NF=.;NG=0.000620;NH=D;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,PolII,ZBTB7A,H3K36me3;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	0/1:41:53:94:.
1	879676	.	G	A	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=NOC2L,SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000188976,UNKNOWN;UCG=unknown;ENS=UTR3;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs6605067;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.89;TASN=0.92;TAFR=0.80;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,H3K27ac,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	879687	.	T	C	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=NOC2L,SAMD11,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187634,ENSG00000188976,UNKNOWN;UCG=unknown;ENS=UTR3;ENSGN=ENSG00000187634;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs2839;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,H3K27ac,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	880238	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748592;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:19:0:19:.
1	881105	.	C	T	1	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,ENSG00000188976,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:2:51:53:.
1	881627	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=NOC2L:NM_015658:exon16:c.C1843T:p.L615L,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976:ENST00000327044:exon16:c.C1843T:p.L615L,,NOC2L:uc009vjq.3:exon16:c.C1843T:p.L615L,NOC2L:uc001aby.4:exon14:c.C1234T:p.L412L,NOC2L:uc001abz.4:exon16:c.C1843T:p.L615L,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs2272757;CD=.;HT=.;HC=.;HD=.;HP=.;AV=688;AT=3716;EV=5486;ET=3114;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.47;TAMR=0.46;TASN=0.61;TAFR=0.08;TEUR=0.63;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=COSM1344685;CGENE=NOC2L;CSTRAND=-;CCDS=c.1843C>T;CAA=p.L615L;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/1:74:54:128:.
1	882033	.	G	A	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,ENSG00000188976,NONE(dist=NONE),NONE(dist=NONE);UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs2272756;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.15;TAMR=0.23;TASN=0.08;TAFR=0.02;TEUR=0.25;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:12:12:24:.
1	883625	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,ENSG00000188976,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs4970378;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4374;AT=2;EV=8576;ET=0;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=1.00;TEUR=1.00;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:209:0:209:.
1	884091	.	C	G	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,ENSG00000188976,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs7522415;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:10:14:.
1	884101	.	A	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs4970455;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	0/1:8:5:13:.
1	884815	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs4246503;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.92;TASN=0.92;TAFR=0.89;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	886788	.	G	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs10465242;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.72;TAMR=0.74;TASN=0.69;TAFR=0.46;TEUR=0.90;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,CTCF,Rad21,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	886817	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs10465241;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.72;TAMR=0.74;TASN=0.69;TAFR=0.46;TEUR=0.90;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,CTCF,Rad21,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	887507	.	A	G	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=NOC2L:NM_015658:exon11:c.T1204C:p.S402P,,ENSG00000188976:ENST00000327044:exon11:c.T1204C:p.S402P,,NONE(dist=NONE),NONE(dist=NONE),NOC2L:uc009vjq.3:exon11:c.T1204C:p.S402P,NOC2L:uc001aby.4:exon9:c.T595C:p.S199P,NOC2L:uc001abz.4:exon11:c.T1204C:p.S402P,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=1.822000;NC=0.020000;NE=0.966,0.966,0.947;NF=D,D,D;NG=0.000090;NH=D;NI=0.975269;NJ=D;NK=2.015;NL=medium;NM=Armadillo-type_fold_(1),;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	0/0:4:249:253:.
1	887560	.	A	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748595;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3662;AT=744;EV=8021;ET=579;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.86;TASN=0.86;TAFR=0.78;TEUR=0.85;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:170:0:170:.
1	887801	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=NOC2L:NM_015658:exon10:c.T1182C:p.T394T,,ENSG00000188976:ENST00000327044:exon10:c.T1182C:p.T394T,,NONE(dist=NONE),NONE(dist=NONE),NOC2L:uc009vjq.3:exon10:c.T1182C:p.T394T,NOC2L:uc001aby.4:exon8:c.T573C:p.T191T,NOC2L:uc001abz.4:exon10:c.T1182C:p.T394T,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3828047;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3992;AT=414;EV=8070;ET=530;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=COSM426785;CGENE=NOC2L;CSTRAND=-;CCDS=c.1182T>C;CAA=p.T394T;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,PolII;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:56:0:56:.
1	888639	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=NOC2L:NM_015658:exon9:c.A918G:p.E306E,,ENSG00000188976:ENST00000327044:exon9:c.A918G:p.E306E,,NONE(dist=NONE),NONE(dist=NONE),NOC2L:uc009vjq.3:exon9:c.A918G:p.E306E,NOC2L:uc001aby.4:exon7:c.A309G:p.E103E,NOC2L:uc001abz.4:exon9:c.A918G:p.E306E,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748596;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3991;AT=415;EV=8069;ET=531;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:330:0:330:.
1	888659	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=NOC2L:NM_015658:exon9:c.A898G:p.I300V,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976:ENST00000327044:exon9:c.A898G:p.I300V,,NOC2L:uc009vjq.3:exon9:c.A898G:p.I300V,NOC2L:uc001aby.4:exon7:c.A289G:p.I97V,NOC2L:uc001abz.4:exon9:c.A898G:p.I300V,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs3748597;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3989;AT=415;EV=8070;ET=530;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.578000;NC=1.000000;NE=0.0;NF=B;NG=0.069598;NH=N;NI=0.000000;NJ=P;NK=-2.24;NL=neutral;NM=Armadillo-type_fold_(1),;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:285:0:285:.
1	889158	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=NOC2L(NM_015658:exon9:c.888+4C>G),NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976(ENST00000327044:exon9:c.888+4C>G),NOC2L(uc001aby.4:exon7:c.279+4C>G,uc001abz.4:exon9:c.888+4C>G,uc009vjq.3:exon9:c.888+4C>G);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303056;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3628;AT=776;EV=8023;ET=573;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.85;TAMR=0.87;TASN=0.88;TAFR=0.79;TEUR=0.85;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:53:0:53:.
1	889159	.	A	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=NOC2L(NM_015658:exon9:c.888+3T>G),ENSG00000188976(ENST00000327044:exon9:c.888+3T>G),NONE(dist=NONE),NONE(dist=NONE),NOC2L(uc001aby.4:exon7:c.279+3T>G,uc001abz.4:exon9:c.888+3T>G,uc009vjq.3:exon9:c.888+3T>G);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13302945;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3626;AT=778;EV=8014;ET=582;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.85;TAMR=0.87;TASN=0.88;TAFR=0.79;TEUR=0.85;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:54:0:54:.
1	889638	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303206;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.90;TASN=0.92;TAFR=0.83;TEUR=0.94;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:9:0:9:.
1	889713	.	C	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303051;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.90;TASN=0.92;TAFR=0.83;TEUR=0.94;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	891021	.	G	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13302957;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.83;TAMR=0.81;TASN=0.77;TAFR=0.75;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	892745	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=UTR5;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303227;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.92;TASN=0.92;TAFR=0.90;TEUR=0.95;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,H2BK5me1,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:33:0:33:.
1	894573	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=NOC2L,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188976;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188976;MT=intergenic;MTGN=.;GN=NOC2L;RSID=rs13303010;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1243;AT=3125;EV=7685;ET=883;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.65;TAMR=0.71;TASN=0.69;TAFR=0.18;TEUR=0.90;SF=Acts_as_an_inhibitor_of_histone_acetyltransferase_activity,_prevents_acetylation_of_all_core_histones_by_the_EP300/p300_histone_acetyltransferase_at_p53/TP53-regulated_target_promoters_in_a_histone_deacetylases_(HDAC)-independent_manner._Acts_as_a_transcription_corepressor_of_p53/TP53-_and_TP63-mediated_transactivation_of_the_p21/CDKN1A_promoter._Involved_in_the_regulation_of_p53/TP53-dependent_apoptosis._Associates_together_with_TP63_isoform_TA*-gamma_to_the_p21/CDKN1A_promoter.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K4me3,H3K4me2,H3K9ac,H3K79me2,H3K27ac,DNase1,H4K91ac,Yy1,Gabp,PolII,Cmyc,Sin3Ak20,ELF1,E2F6,TAF1,HEY1,Max,E2F4;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:77:1:78:.
1	896816	.	G	A	2	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=KLHL17:NM_198317:exon2:c.G251A:p.R84H,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961:ENST00000338591:exon2:c.G251A:p.R84H,,KLHL17:uc001aca.2:exon2:c.G251A:p.R84H,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=2.179000;NC=0.050000;NE=0.888;NF=P;NG=0.000000;NH=D;NI=0.999519;NJ=D;NK=1.345;NL=low;NM=BTB/POZ_(1),BTB/POZ_fold_(2),;ENN=H3K27me3,DNase1,H3K4me3,ZBTB7A,H3K36me3,E2F6,PolII,Max,Cmyc,SETDB1,H4K20me1,H3K4me2,H2BK5me1;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	0/0:2:89:91:.
1	897325	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=KLHL17:NM_198317:exon4:c.G609C:p.A203A,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961:ENST00000338591:exon4:c.G609C:p.A203A,,KLHL17:uc001aca.2:exon4:c.G609C:p.A203A,KLHL17:uc010nya.1:exon2:c.G237C:p.A79A,KLHL17:uc001acb.1:exon2:c.G237C:p.A79A,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs4970441;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3204;AT=1200;EV=7965;ET=635;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.88;TASN=0.92;TAFR=0.71;TEUR=0.94;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:216:0:216:.
1	897564	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE),KLHL17:uc010nya.1:exon2:c.T476C:p.F159S,KLHL17:uc001acb.1:exon2:c.T476C:p.F159S,;UCG=nonsynonymous_SNV;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs13303229;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.91;TASN=0.92;TAFR=0.83;TEUR=0.94;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:19:0:19:.
1	898323	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs6605071;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3992;AT=318;EV=8018;ET=504;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.91;TASN=0.92;TAFR=0.92;TEUR=0.95;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:29:0:29:.
1	899928	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs6677386;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2615;AT=849;EV=6481;ET=467;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.83;TAMR=0.86;TASN=0.92;TAFR=0.56;TEUR=0.92;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:83:0:83:.
1	899937	.	G	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs143296006;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2305;AT=815;EV=5805;ET=435;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.76;TAMR=0.82;TASN=0.87;TAFR=0.49;TEUR=0.83;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:55:0:55:.
1	899938	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs147467971;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.77;TAMR=0.82;TASN=0.88;TAFR=0.51;TEUR=0.83;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:52:0:52:.
1	899942	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs71509448;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2296;AT=784;EV=5857;ET=393;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.83;TASN=0.91;TAFR=0.49;TEUR=0.86;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:50:0:50:.
1	899989	.	A	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs6669071;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.25;TMAF=0.84;TAMR=0.87;TASN=0.91;TAFR=0.64;TEUR=0.91;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=COSN394513;CGENE=KLHL17;CSTRAND=+;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	900285	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs4970435;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.85;TASN=0.92;TAFR=0.45;TEUR=0.94;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:15:0:15:.
1	900286	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187961;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs4970434;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.93;TAMR=0.91;TASN=0.92;TAFR=0.93;TEUR=0.95;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:16:0:16:.
1	900505	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=KLHL17:NM_198317:exon12:c.G1863C:p.V621V,,ENSG00000187961:ENST00000338591:exon12:c.G1863C:p.V621V,,NONE(dist=NONE),NONE(dist=NONE),KLHL17:uc001aca.2:exon12:c.G1863C:p.V621V,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187961;MT=intergenic;MTGN=.;GN=KLHL17;RSID=rs28705211;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.16;TAMR=0.22;TASN=0.09;TAFR=0.02;TEUR=0.28;SF=Substrate-recognition_component_of_some_cullin-RING-_based_BCR_(BTB-CUL3-RBX1)_E3_ubiquitin-protein_ligase_complex._The_BCR(KLHL17)_mediates_the_ubiquitination_and_subsequenct_degradation_of_GLUR6._May_play_a_role_in_the_actin-based_neuronal_function_(By_similarity).;SD=.;SM=.;SX=.;CID=COSM426805;CGENE=KLHL17;CSTRAND=+;CCDS=c.1863G>C;CAA=p.V621V;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:75:68:143:.
1	901559	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream,downstream;GI=PLEKHN1,KLHL17,ENSG00000187583,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE);UCG=upstream,downstream;ENS=upstream,downstream;ENSGN=ENSG00000187583,ENSG00000187961;MT=intergenic;MTGN=.;GN=PLEKHN1,KLHL17;RSID=rs13303160;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.67;TAMR=0.71;TASN=0.70;TAFR=0.25;TEUR=0.90;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,DNase1,PolII,H3K4me2,ZBTB7A,Gabp,H3K4me3,H3K27ac,Max;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	901607	.	C	G	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream,downstream;GI=PLEKHN1,KLHL17,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583,ENSG00000187961;UCG=upstream,downstream;ENS=upstream,downstream;ENSGN=ENSG00000187583,ENSG00000187961;MT=intergenic;MTGN=.;GN=PLEKHN1,KLHL17;RSID=rs13302996;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.83;TAMR=0.88;TASN=0.91;TAFR=0.55;TEUR=0.93;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,DNase1,PolII,H3K4me2,ZBTB7A,Gabp,H3K4me3,H3K27ac,Max,ZEB1,H3K9ac;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	901652	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream,downstream;GI=PLEKHN1,KLHL17,ENSG00000187583,ENSG00000187961,NONE(dist=NONE),NONE(dist=NONE);UCG=upstream,downstream;ENS=upstream,downstream;ENSGN=ENSG00000187583,ENSG00000187961;MT=intergenic;MTGN=.;GN=PLEKHN1,KLHL17;RSID=rs2879814;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=0.99;TEUR=1.00;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,DNase1,PolII,H3K4me2,ZBTB7A,Gabp,H3K4me3,H3K27ac,Max,ZEB1,H3K9ac;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	901880	.	A	G	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=PLEKHN1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,DNase1,PolII,H3K4me2,H3K4me3,H3K27ac,Max,ZEB1,H3K9ac,E2F6,Ap2alpha;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	0/0:3:198:201:.
1	908823	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,ENSG00000187583,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs28687780;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.12;TAMR=0.18;TASN=0.08;TAFR=0.07;TEUR=0.16;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:10:9:19:.
1	909053	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,ENSG00000187583,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs116854740;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2;AT=4402;EV=40;ET=8550;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.01;TAMR=0.05;TASN=0.0035;TAFR=.;TEUR=0.01;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:17:8:25:.
1	909073	.	C	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,ENSG00000187583,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs3892467;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.40;TAMR=0.35;TASN=0.63;TAFR=0.18;TEUR=0.40;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:8:12:20:.
1	909238	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=PLEKHN1:NM_001160184:exon13:c.G1355C:p.R452P,PLEKHN1:NM_032129:exon14:c.G1460C:p.R487P,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583:ENST00000379409:exon13:c.G1616C:p.R539P,ENSG00000187583:ENST00000491024:exon2:c.G155C:p.R52P,ENSG00000187583:ENST00000379407:exon13:c.G1355C:p.R452P,ENSG00000187583:ENST00000379410:exon14:c.G1460C:p.R487P,,PLEKHN1:uc001acd.3:exon14:c.G1460C:p.R487P,PLEKHN1:uc001ace.3:exon13:c.G1616C:p.R539P,PLEKHN1:uc001acf.3:exon13:c.G1355C:p.R452P,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs3829740;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3431;AT=963;EV=5009;ET=3579;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.74;TAMR=0.67;TASN=0.89;TAFR=0.81;TEUR=0.61;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.456000;NC=0.280000;NE=0.0,0.0,0.0;NF=B,B,B;NG=0.413783;NH=N;NI=0.000026;NJ=N;NK=-0.55;NL=neutral;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:91:1:92:.
1	909309	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=PLEKHN1:NM_001160184:exon13:c.T1426C:p.S476P,PLEKHN1:NM_032129:exon14:c.T1531C:p.S511P,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583:ENST00000379409:exon13:c.T1687C:p.S563P,ENSG00000187583:ENST00000491024:exon2:c.T226C:p.S76P,ENSG00000187583:ENST00000379407:exon13:c.T1426C:p.S476P,ENSG00000187583:ENST00000379410:exon14:c.T1531C:p.S511P,,PLEKHN1:uc001acd.3:exon14:c.T1531C:p.S511P,PLEKHN1:uc001ace.3:exon13:c.T1687C:p.S563P,PLEKHN1:uc001acf.3:exon13:c.T1426C:p.S476P,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs3829738;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1067;AT=3331;EV=1463;ET=7121;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.22;TAMR=0.23;TASN=0.27;TAFR=0.21;TEUR=0.18;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-1.637000;NC=0.300000;NE=0.001,0.001,0.001;NF=B,B,B;NG=0.668062;NH=N;NI=0.083092;NJ=N;NK=0.895;NL=low;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:46:80:126:.
1	909555	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,ENSG00000187583,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs2340594;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.94;TASN=0.97;TAFR=0.72;TEUR=0.98;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:18:0:18:.
1	909768	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=PLEKHN1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs2340593;CD=.;HT=.;HC=.;HD=.;HP=.;AV=4404;AT=2;EV=8600;ET=0;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=1.00;TAMR=1.00;TASN=1.00;TAFR=1.00;TEUR=1.00;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:116:0:116:.
1	910394	.	C	T	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=PLEKHN1,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187583;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs28477686;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.43;TAMR=0.41;TASN=0.49;TAFR=0.56;TEUR=0.32;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:7:2:9:.
1	910434	.	G	A	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=PLEKHN1,ENSG00000187583,NONE(dist=NONE),NONE(dist=NONE);UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs188543497;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.01;TAMR=0.04;TASN=0.01;TAFR=0.0020;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:3:7:.
1	910438	.	A	G	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=PLEKHN1,ENSG00000187583,NONE(dist=NONE),NONE(dist=NONE);UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000187583;MT=intergenic;MTGN=.;GN=PLEKHN1;RSID=rs6685581;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.94;TASN=1.00;TAFR=0.74;TEUR=0.97;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	911595	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000341290:exon5:c.T1988C:p.V663A,ENSG00000187642:ENST00000433179:exon5:c.T2048C:p.V683A,,C1orf170:uc001ach.2:exon5:c.T1988C:p.V663A,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs7417106;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.74;TAMR=0.77;TASN=0.93;TAFR=0.41;TEUR=0.78;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.265000;NC=0.000000;NE=0.103;NF=B;NG=0.174340;NH=N;NI=0.027941;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H3K4me2,CTCF,Gabp,Rad21,H4K20me1,H3K4me3;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:126:0:126:.
1	912049	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,ENSG00000187642,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs9803103;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.54;TAMR=0.58;TASN=0.71;TAFR=0.22;TEUR=0.59;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,H4K20me1,H3K4me3,H3K4me2;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:49:56:105:.
1	912103	.	G	A	60	single_strand	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,ENSG00000187642,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs9803017;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.2;TMAF=0.48;TAMR=0.53;TASN=0.55;TAFR=0.32;TEUR=0.49;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:27:0:27:.
1	912126	.	G	A	59	low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,ENSG00000187642,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs75056944;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.166667;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	914192	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,ENSG00000187642,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs2340595;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.93;TASN=1.00;TAFR=0.77;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:48:0:48:.
1	914333	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.G1735C:p.E579Q,ENSG00000187642:ENST00000433179:exon3:c.G1795C:p.E599Q,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.G1735C:p.E579Q,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13302979;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.57;TAMR=0.61;TASN=0.79;TAFR=0.23;TEUR=0.61;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.888000;NC=0.460000;NE=0.0;NF=B;NG=0.001941;NH=N;NI=0.000018;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:17:15:32:.
1	914526	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.G1542A:p.S514S,ENSG00000187642:ENST00000433179:exon3:c.G1602A:p.S534S,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.G1542A:p.S514S,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:40:41:81:.
1	914852	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.C1216G:p.Q406E,ENSG00000187642:ENST00000433179:exon3:c.C1276G:p.Q426E,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.C1216G:p.Q406E,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13303368;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.53;TAMR=0.59;TASN=0.71;TAFR=0.19;TEUR=0.60;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.049000;NC=1.000000;NE=0.0;NF=B;NG=0.000001;NH=N;NI=0.000015;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	0/1:46:78:124:.
1	914876	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.A1192G:p.S398G,ENSG00000187642:ENST00000433179:exon3:c.A1252G:p.S418G,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.A1192G:p.S398G,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13302983;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.94;TASN=0.99;TAFR=0.92;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.248000;NC=0.430000;NE=0.004;NF=B;NG=0.211142;NH=N;NI=0.000786;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:161:2:163:.
1	914940	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000341290:exon3:c.A1128G:p.A376A,ENSG00000187642:ENST00000433179:exon3:c.A1188G:p.A396A,,C1orf170:uc001ach.2:exon3:c.A1128G:p.A376A,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13303033;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.52;TAMR=0.57;TASN=0.71;TAFR=0.18;TEUR=0.59;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:63:116:179:.
1	915227	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000341290:exon3:c.T841C:p.L281L,ENSG00000187642:ENST00000433179:exon3:c.T901C:p.L301L,,C1orf170:uc001ach.2:exon3:c.T841C:p.L281L,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs13303355;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.93;TASN=1.00;TAFR=0.72;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:68:0:68:.
1	915325	.	A	G	60	single_strand;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.T743C:p.I248T,ENSG00000187642:ENST00000433179:exon3:c.T803C:p.I268T,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.T743C:p.I248T,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=0.391000;NC=1.000000;NE=0.0;NF=B;NG=0.051885;NH=N;NI=0.000100;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:7:213:220:.
1	915350	.	G	A	2	low_snpqual;single_strand;low_VariantReads;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.C718T:p.P240S,ENSG00000187642:ENST00000433179:exon3:c.C778T:p.P260S,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.C718T:p.P240S,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.618000;NC=0.130000;NE=0.031;NF=B;NG=0.659857;NH=N;NI=0.000097;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:2:263:265:.
1	915388	.	G	C	59	single_strand;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,ENSG00000187642:ENST00000341290:exon3:c.C680G:p.T227R,ENSG00000187642:ENST00000433179:exon3:c.C740G:p.T247R,,NONE(dist=NONE),NONE(dist=NONE),C1orf170:uc001ach.2:exon3:c.C680G:p.T227R,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-3.562000;NC=0.510000;NE=0.0;NF=B;NG=.;NH=.;NI=0.124243;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:11:259:270:.
1	915440	.	A	G	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000341290:exon3:c.T628C:p.S210P,ENSG00000187642:ENST00000433179:exon3:c.T688C:p.S230P,,C1orf170:uc001ach.2:exon3:c.T628C:p.S210P,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.569000;NC=1.000000;NE=0.0;NF=B;NG=0.014995;NH=N;NI=0.069854;NJ=N;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:5:255:260:.
1	916549	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_exonic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642:ENST00000433179:exon2:c.T58C:p.W20R,;UCG=UTR5;ENS=nonsynonymous_SNV;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=rs6660139;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.74;TAMR=0.74;TASN=0.87;TAFR=0.57;TEUR=0.76;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-0.945000;NC=0.370000;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:82:79:161:.
1	916610	.	G	T	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=ncRNA_intronic;GI=C1orf170,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187642;MT=intergenic;MTGN=.;GN=C1orf170;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:3:100:103:.
1	918573	.	A	G	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=C1orf170(dist=1100),HES4(dist=15769),ENSG00000187642(dist=1076),ENSG00000188290(dist=15769),NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs2341354;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.57;TAMR=0.61;TASN=0.81;TAFR=0.23;TEUR=0.60;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:7:4:11:.
1	919419	.	T	C	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=C1orf170(dist=1946),HES4(dist=14923),ENSG00000187642(dist=1922),ENSG00000188290(dist=14923),NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs6605059;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.84;TASN=0.85;TAFR=0.84;TEUR=0.77;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,CTCF;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	926621	.	A	C	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=C1orf170(dist=9148),HES4(dist=7721),NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642(dist=9124),ENSG00000188290(dist=7721);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs4970351;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=0.96;TAFR=0.68;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	928373	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=C1orf170(dist=10900),HES4(dist=5969),NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642(dist=10876),ENSG00000188290(dist=5969);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs79271194;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.93;TASN=0.96;TAFR=0.77;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	932618	.	C	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=C1orf170(dist=15145),HES4(dist=1724),NONE(dist=NONE),NONE(dist=NONE),ENSG00000187642(dist=15121),ENSG00000188290(dist=1724);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs3128112;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.96;TAMR=0.94;TASN=1.00;TAFR=0.91;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	935222	.	C	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=HES4:NM_001142467:exon1:c.G132T:p.R44S,,ENSG00000188290:ENST00000428771:exon1:c.G132T:p.R44S,,NONE(dist=NONE),NONE(dist=NONE),HES4:uc010nyc.1:exon1:c.G132T:p.R44S,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000188290;MT=intergenic;MTGN=.;GN=HES4;RSID=rs2298214;CD=.;HT=.;HC=.;HD=.;HP=.;AV=455;AT=2827;EV=4195;ET=3171;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.51;TAMR=0.59;TASN=0.76;TAFR=0.05;TEUR=0.59;SF=Transcriptional_repressor._Binds_DNA_on_N-box_motifs:_5'-CACNAG-3'_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=-1.612000;NC=1.000000;NE=0.001;NF=B;NG=.;NH=.;NI=.;NJ=.;NK=0;NL=neutral;NM=.;ENN=H3K27me3,DNase1,E2F6,H3K4me3,H3K9ac,PolII,H3K4me2,E2F1,TAF1,Ap2alpha;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	936111	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream;GI=HES4,ENSG00000188290,NONE(dist=NONE),NONE(dist=NONE);UCG=upstream;ENS=upstream;ENSGN=ENSG00000188290;MT=intergenic;MTGN=.;GN=HES4;RSID=rs1936360;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.54;TAMR=0.60;TASN=0.75;TAFR=0.20;TEUR=0.58;SF=Transcriptional_repressor._Binds_DNA_on_N-box_motifs:_5'-CACNAG-3'_(By_similarity).;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,DNase1,E2F6,H3K4me3,H3K9ac,PolII,TAF1,Ap2gamma,Max,E2F4,ZBTB7A,Cmyc,H3K4me2,H3K27ac,HEY1,H4K91ac,H2AZ,H3K18ac,SETDB1,H4K20me1,Sin3Ak20,Srf,Gabp,Jund,Cjun,USF1,Junb;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:13:0:13:.
1	940096	.	C	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=HES4(dist=4544),ISG15(dist=8751),ENSG00000188290(dist=4544),ENSG00000231702(dist=3360),NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs4503294;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.55;TAMR=0.61;TASN=0.78;TAFR=0.20;TEUR=0.57;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PolII,H3K4me2,H3K4me3,H3K4me1,H3K9ac,H3K27ac;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	943468	.	T	C	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=HES4(dist=7916),ISG15(dist=5379),ENSG00000231702,NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=ncRNA_exonic;ENSGN=ENSG00000231702;MT=intergenic;MTGN=.;GN=.;RSID=rs3121567;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.62;TEUR=0.96;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	948692	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=upstream;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608,ENSG00000224969;UCG=upstream;ENS=upstream;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs2341365;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.91;TASN=0.92;TAFR=0.44;TEUR=0.95;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me2,H3K4me3,DNase1,H2AZ,H3K56ac,BATF,H2BK120ac,H4K8ac,Max,Cmyc,PolII,H2BK5ac,TAF1,ELF1,HEY1,H3K36ac,Ap2gamma,Sin3Ak20,MEF2A,Ap2alpha,Srf,Tcf12,FAIRE;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:10:0:10:.
1	948870	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=ISG15,ENSG00000187608,NONE(dist=NONE),NONE(dist=NONE);UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs4615788;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1016;AT=358;EV=3015;ET=141;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.93;TASN=1.00;TAFR=0.67;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me3,H3K4me2,DNase1,Max,Cmyc,PolII,H2BK5ac,TAF1,ELF1,HEY1,Ap2gamma,Sin3Ak20,MEF2A,Ap2alpha,Srf,Tcf12,FAIRE,H3K36me3,POU2F2,H3K79me2,H2AZ;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:122:0:122:.
1	948921	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs15842;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3294;AT=1110;EV=8223;ET=375;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.93;TASN=1.00;TAFR=0.67;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me3,H3K4me2,DNase1,Max,Cmyc,PolII,H2BK5ac,TAF1,ELF1,HEY1,Ap2gamma,Sin3Ak20,MEF2A,Ap2alpha,Srf,Tcf12,FAIRE,H3K36me3,POU2F2,H3K79me2,H2AZ,H3K18ac,Znf263,H3K9me1;ENC=Histone,Open_Chromatin,Transcription_Factor,Polymerase	GT:VR:RR:DP:GQ	1/1:196:1:197:.
1	949235	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=ISG15,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608;UCG=intronic;ENS=intronic;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs2465124;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.92;TASN=1.00;TAFR=0.65;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,H3K9ac,H3K4me3,H3K4me2,DNase1,H2BK5ac,PolII,H3K36me3,H3K79me2,H2AZ,H3K18ac,Znf263,H3K9me1,H4K91ac,H3K4me1,H2BK5me1,H2BK20ac,H4K20me1;ENC=Histone,Open_Chromatin,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:35:0:35:.
1	949654	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=ISG15:NM_005101:exon2:c.A294G:p.V98V,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000187608:ENST00000379389:exon2:c.A294G:p.V98V,,ISG15:uc001acj.4:exon2:c.A294G:p.V98V,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs8997;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2526;AT=1880;EV=8142;ET=456;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.90;TASN=0.92;TAFR=0.45;TEUR=0.94;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27ac,H3K9ac,H3K4me2,H3K4me3,H3K27me3,PolII,H3K36me3,H3K79me2,H4K91ac,DNase1;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:123:0:123:.
1	949925	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=ISG15,ENSG00000187608,NONE(dist=NONE),NONE(dist=NONE);UCG=downstream;ENS=downstream;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs2799070;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.92;TASN=0.97;TAFR=0.58;TEUR=0.95;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27ac,H3K9ac,H3K4me3,H3K27me3,PolII,H3K36me3,H3K79me2,H3K4me2,H4K91ac,DNase1,Yy1;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:21:2:23:.
1	950677	.	T	C	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=ISG15,ENSG00000187608,NONE(dist=NONE),NONE(dist=NONE);UCG=downstream;ENS=downstream;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs9331223;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.53;TAMR=0.62;TASN=0.74;TAFR=0.17;TEUR=0.56;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,PolII,H3K36me3;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	950716	.	A	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=ISG15,ENSG00000187608,NONE(dist=NONE),NONE(dist=NONE);UCG=downstream;ENS=downstream;ENSGN=ENSG00000187608;MT=intergenic;MTGN=.;GN=ISG15;RSID=rs2799069;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.93;TASN=1.00;TAFR=0.73;TEUR=0.96;SF=Ubiquitin-like_protein_which_plays_a_key_role_in_the_innate_immune_response_to_viral_infection_either_via_its_conjugation_to_a_target_protein_(ISGylation)_or_via_its_action_as_a_free_or_unconjugated_protein._ISGylation_involves_a_cascade_of_enzymatic_reactions_involving_E1,_E2,_and_E3_enzymes_which_catalyze_the_conjugation_of_ISG15_to_a_lysine_residue_in_the_target_protein._Its_target_proteins_include_IFIT1,_MX1/MxA,_PPM1B,_UBE2L6,_UBA7,_CHMP5,_CHMP2A,_CHMP4B_and_CHMP6._Can_also_isgylate:_EIF2AK2/PKR_which_results_in_its_activation,_DDX58/RIG-I_which_inhibits_its_function_in_antiviral_signaling_response,_EIF4E2_which_enhances_its_cap_structure-binding_activity_and_translation-_inhibition_activity,_UBE2N_and_UBE2E1_which_negatively_regulates_their_activity,_IRF3_which_inhibits_its_ubiquitination_and_degradation_and_FLNB_which_prevents_its_ability_to_interact_with_the_upstream_activators_of_the_JNK_cascade_therby_inhibiting_IFNA-_induced_JNK_signaling._Exhibits_antiviral_activity_towards_both_DNA_and_RNA_viruses,_including_influenza_A,_HIV-1_and_Ebola_virus._Restricts_HIV-1_and_ebola_virus_via_disruption_of_viral_budding._Inhibits_the_ubiquitination_of_HIV-1_Gag_and_host_TSG101_and_disrupts_their_interaction,_thereby_preventing_assembly_and_release_of_virions_from_infected_cells._Inhibits_Ebola_virus_budding_mediated_by_the_VP40_protein_by_disrupting_ubiquitin_ligase_activity_of_NEDD4_and_its_ability_to_ubiquitinate_VP40._ISGylates_influenza_A_virus_NS1_protein_which_causes_a_loss_of_function_of_the_protein_and_the_inhibition_of_virus_replication._The_secreted_form_of_ISG15_can:_induce_natural_killer_cell_proliferation,_act_as_a_chemotactic_factor_for_neutrophils_and_act_as_a_IFN-gamma-inducing_cytokine_playing_an_essential_role_in_antimycobacterial_immunity.;SD=.;SM=Induced_as_an_inactive,_precursor_protein_that_is_cleaved_by_specific_proteases_to_expose_the_C-terminal_diglycine_(LRLRGG)_motif._This_motif_is_essential_not_only_for_its_conjugation_to_substrates_but_also_for_its_recognition_by_the_relevant_processing_proteases.;SX=Detected_in_lymphoid_cells,_striated_and_smooth_muscle,_several_epithelia_and_neurons._Expressed_in_neutrophils,_monocytes_and_lymphocytes._Enhanced_expression_seen_in_pancreatic_adenocarcinoma,_endometrial_cancer,_and_bladder_cancer,_as_compared_to_non-cancerous_tissue._In_bladder_cancer,_the_increase_in_expression_exhibits_a_striking_positive_correlation_with_more_advanced_stages_of_the_disease.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=PolII,H3K36me3,CTCF;ENC=Polymerase,Histone,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	957971	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs61766301;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:7:3:10:.
1	957975	.	C	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs375552979;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:3:7:.
1	957976	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs368531584;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:4:3:7:.
1	959155	.	G	A	1	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3845291;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.50;TAMR=0.58;TASN=0.73;TAFR=0.12;TEUR=0.53;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	959169	.	G	C	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3845292;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.56;TAMR=0.60;TASN=0.80;TAFR=0.29;TEUR=0.54;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	961827	.	G	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3121556;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.92;TASN=0.97;TAFR=0.50;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:4:0:4:.
1	962891	.	C	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs4970394;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.59;TAMR=0.65;TASN=0.81;TAFR=0.29;TEUR=0.58;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	963013	.	C	T	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs9442389;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.51;TAMR=0.52;TASN=0.78;TAFR=0.22;TEUR=0.48;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:5:3:8:.
1	963702	.	C	A	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs28741055;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:5:1:6:.
1	965175	.	A	G	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs28373660;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.89;TASN=1.00;TAFR=0.44;TEUR=0.89;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,PolII,H4K20me1,H2BK5me1,DNase1,CTCF;ENC=Histone,Polymerase,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	973336	.	A	G	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2488993;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,HNF4A;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	973458	.	C	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465130;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.66;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,DNase1,HNF4A,HNF4G;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	974180	.	G	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3121577;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PU1,SP1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	974199	.	C	T	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465131;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PU1,SP1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	974225	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2488995;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PU1,SP1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	974296	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2488996;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PU1,SP1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	974355	.	G	A	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2488997;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.88;TAMR=0.92;TASN=0.98;TAFR=0.68;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3,PU1,SP1,DNase1;ENC=Histone,Transcription_Factor,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	974570	.	T	G	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465134;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	974662	.	G	T	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465135;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.90;TAMR=0.94;TASN=1.00;TAFR=0.73;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	977203	.	G	C	1	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3121552;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.69;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	977330	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2799066;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3167;AT=1235;EV=7915;ET=681;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.89;TAMR=0.93;TASN=1.00;TAFR=0.67;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:79:0:79:.
1	977570	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710876;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2083;AT=2203;EV=7804;ET=682;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.91;TASN=0.97;TAFR=0.37;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:35:0:35:.
1	980460	.	G	A	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128097;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.94;TASN=1.00;TAFR=0.76;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:153:1:154:.
1	981087	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128098;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2850;AT=1556;EV=7972;ET=628;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.87;TAMR=0.92;TASN=1.00;TAFR=0.60;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:104:0:104:.
1	981537	.	C	T	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=AGRN(NM_198576:exon17:c.2806-3C>T),NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157(ENST00000379370:exon17:c.2806-3C>T),AGRN(uc001ack.2:exon17:c.2806-3C>T);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:3:147:150:.
1	981931	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon18:c.A3066G:p.S1022S,,ENSG00000188157:ENST00000379370:exon18:c.A3066G:p.S1022S,,NONE(dist=NONE),NONE(dist=NONE),AGRN:uc001ack.2:exon18:c.A3066G:p.S1022S,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2465128;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2316;AT=2080;EV=7819;ET=775;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.90;TASN=0.96;TAFR=0.45;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=COSM1126908;CGENE=AGRN;CSTRAND=+;CCDS=c.3066A>G;CAA=p.S1022S;CCNT=1;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:44:0:44:.
1	982444	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128099;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.92;TASN=0.97;TAFR=0.49;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:13:0:13:.
1	982462	.	T	C	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128100;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.98;TAMR=0.98;TASN=1.00;TAFR=0.92;TEUR=1.00;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:10:0:10:.
1	982513	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128101;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.92;TAMR=0.94;TASN=1.00;TAFR=0.80;TEUR=0.93;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:10:0:10:.
1	982798	.	A	G	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon20:c.A3480G:p.E1160E,,AGRN:uc001ack.2:exon20:c.A3480G:p.E1160E,,ENSG00000188157:ENST00000379370:exon20:c.A3480G:p.E1160E,,NONE(dist=NONE),NONE(dist=NONE);UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:4:151:155:.
1	982941	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3128102;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2098;AT=2308;EV=7869;ET=727;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.82;TAMR=0.91;TASN=0.97;TAFR=0.41;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:142:3:145:.
1	982994	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon21:c.T3558C:p.F1186F,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157:ENST00000379370:exon21:c.T3558C:p.F1186F,,AGRN:uc001ack.2:exon21:c.T3558C:p.F1186F,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs10267;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2389;AT=2017;EV=7901;ET=699;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.84;TAMR=0.91;TASN=0.99;TAFR=0.49;TEUR=0.92;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:212:3:215:.
1	984302	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon24:c.T4161C:p.T1387T,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157:ENST00000379370:exon24:c.T4161C:p.T1387T,,AGRN:uc001ack.2:exon24:c.T4161C:p.T1387T,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs9442391;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1203;AT=3103;EV=4672;ET=3832;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.57;TAMR=0.62;TASN=0.81;TAFR=0.24;TEUR=0.57;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:147:0:147:.
1	984883	.	G	T	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:3:53:56:.
1	985266	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2275813;CD=.;HT=.;HC=.;HD=.;HP=.;AV=693;AT=3681;EV=4482;ET=4010;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.53;TAMR=0.61;TASN=0.80;TAFR=0.10;TEUR=0.55;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:57:0:57:.
1	985446	.	G	T	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2275812;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.31;TAMR=0.43;TASN=0.25;TAFR=0.06;TEUR=0.45;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:19:4:23:.
1	985449	.	G	A	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2799067;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.47;TAMR=0.52;TASN=0.51;TAFR=0.26;TEUR=0.56;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/1:18:6:24:.
1	985693	.	T	C	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=nonsynonymous_SNV;GI=AGRN:NM_198576:exon28:c.T4960C:p.F1654L,,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157:ENST00000379370:exon28:c.T4960C:p.F1654L,,AGRN:uc001ack.2:exon28:c.T4960C:p.F1654L,;UCG=nonsynonymous_SNV;ENS=nonsynonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=1.761000;NC=0.650000;NE=0.011;NF=B;NG=0.000476;NH=U;NI=0.633544;NJ=D;NK=0.69;NL=neutral;NM=Concanavalin_A-like_lectin/glucanase_(1),Concanavalin_A-like_lectin/glucanase,_subgroup_(1),Laminin_G_domain_(1),;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:7:231:238:.
1	986443	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710887;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.88;TASN=1.00;TAFR=0.36;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:105:0:105:.
1	987200	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=splicing;GI=AGRN(NM_198576:exon33:c.5651+5C>T),AGRN(uc001ack.2:exon33:c.5651+5C>T),ENSG00000188157(ENST00000379370:exon33:c.5651+5C>T,ENST00000419249:exon6:c.558+5C>T),NONE(dist=NONE),NONE(dist=NONE);UCG=splicing;ENS=splicing;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs9803031;CD=.;HT=.;HC=.;HD=.;HP=.;AV=2016;AT=2386;EV=7824;ET=774;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.89;TASN=1.00;TAFR=0.37;TEUR=0.91;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:212:0:212:.
1	987389	.	A	G	2	low_snpqual;low_VariantRatio	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),UNKNOWN;UCG=intronic;ENS=unknown;ENSGN=UNKNOWN;MT=intergenic;MTGN=.;GN=AGRN;RSID=.;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=1.923000;NC=0.510000;NE=.;NF=.;NG=.;NH=.;NI=0.289388;NJ=N;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	0/0:4:169:173:.
1	988932	.	G	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=AGRN,ENSG00000188157,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710871;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.88;TASN=1.00;TAFR=0.35;TEUR=0.86;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:35:0:35:.
1	990280	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=synonymous_SNV;GI=AGRN:NM_198576:exon36:c.C6057T:p.D2019D,,ENSG00000188157:ENST00000379370:exon36:c.C6057T:p.D2019D,,NONE(dist=NONE),NONE(dist=NONE),AGRN:uc001ack.2:exon36:c.C6057T:p.D2019D,;UCG=synonymous_SNV;ENS=synonymous_SNV;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs4275402;CD=.;HT=.;HC=.;HD=.;HP=.;AV=1425;AT=2865;EV=5921;ET=2473;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.62;TAMR=0.69;TASN=0.80;TAFR=0.26;TEUR=0.69;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:158:0:158:.
1	990517	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=AGRN,ENSG00000242590,NONE(dist=NONE),NONE(dist=NONE);UCG=UTR3;ENS=ncRNA_exonic;ENSGN=ENSG00000242590;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710872;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.92;TASN=1.00;TAFR=0.83;TEUR=0.88;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	990773	.	C	T	2	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=UTR3;ENS=ncRNA_UTR3;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2799072;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.85;TAMR=0.91;TASN=1.00;TAFR=0.59;TEUR=0.87;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	990984	.	G	A	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157;UCG=UTR3;ENS=ncRNA_UTR3;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs8014;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.94;TASN=1.00;TAFR=0.85;TEUR=0.88;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	991724	.	C	T	1	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=AGRN,NONE(dist=NONE),NONE(dist=NONE),ENSG00000188157,ENSG00000242590;UCG=downstream;ENS=downstream;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs3121562;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.78;TAMR=0.87;TASN=0.99;TAFR=0.36;TEUR=0.86;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,PolII,Srf;ENC=Histone,Polymerase,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	992084	.	T	C	2	low_snpqual;low_coverage;low_VariantReads	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=AGRN,ENSG00000188157,ENSG00000242590,NONE(dist=NONE),NONE(dist=NONE);UCG=downstream;ENS=downstream;ENSGN=ENSG00000188157;MT=intergenic;MTGN=.;GN=AGRN;RSID=rs2710886;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.91;TAMR=0.94;TASN=1.00;TAFR=0.84;TEUR=0.88;SF=Agrin_C-terminal_22_kDa_fragment:_this_released_fragment_is_important_for_agrin_signaling_and_to_exert_a_maximal_dendritic_filopodia-inducing_effect._All_'z'_splice_variants_(z+)_of_this_fragment_also_show_an_increase_in_the_number_of_filopodia.;SD=Myasthenia,_limb-girdle,_familial_(LGM)_[MIM:254300]:_A_congenital_myasthenic_syndrome_characterized_by_a_typical_'limb_girdle'_pattern_of_muscle_weakness_with_small,_simplified_neuromuscular_junctions_but_normal_acetylcholine_receptor_and_acetylcholinesterase_function._Note=The_disease_is_caused_by_mutations_affecting_the_gene_represented_in_this_entry.;SM=At_synaptic_junctions,_cleaved_at_two_conserved_sites,_alpha_and_beta,_by_neurotrypsin._Cleavage_at_the_alpha-site_produces_the_agrin_N-terminal_110-kDa_subunit_and_the_agrin_C-terminal_110-kDa_subunit._Further_cleavage_of_agrin_C-terminal_110-kDa_subunit_at_the_beta_site_produces_the_C-terminal_fragments,_agrin_C-terminal_90_kDa_fragment_and_agrin_C-terminal_22_kDa_fragment._Excessive_cleavage_at_the_beta-site_releases_large_amounts_of_the_agrin_C-_terminal_22_kDa_fragment_leading_to_destabilization_at_the_neuromuscular_junction_(NMJ).;SX=Expressed_in_basement_membranes_of_lung_and_kidney._Muscle-_and_neuron-specific_isoforms_are_found._Isoforms_(y+)_with_the_4_AA_insert_and_(z+8)_isoforms_with_the_8_AA_insert_are_all_neuron-specific._Isoforms_(z+11)_are_found_in_both_neuronal_and_non-neuronal_tissues.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,H3K27me3,PolII,H2BK5me1;ENC=Histone,Polymerase	GT:VR:RR:DP:GQ	1/1:2:0:2:.
1	998395	.	A	G	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=AGRN(dist=6896),RNF223(dist=8731),NONE(dist=NONE),NONE(dist=NONE),ENSG00000217801,BC033949;UCG=ncRNA_intronic;ENS=ncRNA_intronic;ENSGN=ENSG00000217801;MT=intergenic;MTGN=.;GN=AGRN(dist=6896);RSID=rs7526076;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.81;TAMR=0.80;TASN=0.91;TAFR=0.81;TEUR=0.74;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1;ENC=Histone	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	1003053	.	C	T	1	low_snpqual	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=AGRN(dist=11554),RNF223(dist=4073),ENSG00000217801,NONE(dist=NONE),NONE(dist=NONE),BC033949(dist=1220),RNF223(dist=4073);UCG=intergenic;ENS=ncRNA_intronic;ENSGN=ENSG00000217801;MT=intergenic;MTGN=.;GN=.;RSID=rs4074992;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.49;TAMR=0.59;TASN=0.77;TAFR=0.08;TEUR=0.50;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H4K20me1,DNase1,ZEB1;ENC=Histone,Open_Chromatin,Transcription_Factor	GT:VR:RR:DP:GQ	1/1:6:0:6:.
1	1009478	.	G	C	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR5;GI=RNF223,NONE(dist=NONE),NONE(dist=NONE),ENSG00000237330;UCG=UTR5;ENS=UTR5;ENSGN=ENSG00000237330;MT=intergenic;MTGN=.;GN=RNF223;RSID=rs9442367;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.80;TAMR=0.78;TASN=0.92;TAFR=0.80;TEUR=0.72;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K4me3,PolII,DNase1,H3K36me3;ENC=Histone,Polymerase,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:8:0:8:.
1	1011637	.	A	T	2	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=RNF223(dist=1950),C1orf159(dist=5561),ENSG00000237330(dist=1950),ENSG00000131591(dist=5561),NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs374272466;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=0.0384615;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	1014716	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intergenic;GI=RNF223(dist=5029),C1orf159(dist=2482),ENSG00000237330(dist=5029),ENSG00000131591(dist=2482),NONE(dist=NONE),NONE(dist=NONE);UCG=intergenic;ENS=intergenic;ENSGN=.;MT=intergenic;MTGN=.;GN=.;RSID=rs375737918;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=.;TAMR=.;TASN=.;TAFR=.;TEUR=.;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K27me3,H3K27ac,DNase1,PolII;ENC=Histone,Open_Chromatin,Polymerase	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	1017170	.	C	G	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=downstream;GI=C1orf159,ENSG00000131591,NONE(dist=NONE),NONE(dist=NONE);UCG=downstream;ENS=downstream;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs3766193;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.59;TAMR=0.64;TASN=0.78;TAFR=0.39;TEUR=0.55;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	1018144	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=UTR3;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=UTR3;ENS=UTR3;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442395;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.56;TAMR=0.63;TASN=0.77;TAFR=0.26;TEUR=0.56;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:23:0:23:.
1	1018562	.	C	T	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,ENSG00000131591,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442371;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.55;TAMR=0.62;TASN=0.77;TAFR=0.22;TEUR=0.56;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:7:0:7:.
1	1018704	.	A	G	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,ENSG00000131591,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442372;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.62;TAMR=0.65;TASN=0.78;TAFR=0.50;TEUR=0.56;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:3:0:3:.
1	1019175	.	C	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs2298215;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.71;TAMR=0.75;TASN=0.90;TAFR=0.46;TEUR=0.72;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:14:0:14:.
1	1019180	.	T	C	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,ENSG00000131591,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442396;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.61;TAMR=0.65;TASN=0.77;TAFR=0.46;TEUR=0.57;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:15:0:15:.
1	1021415	.	A	G	60	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs3737728;CD=.;HT=.;HC=.;HD=.;HP=.;AV=3413;AT=987;EV=6204;ET=2392;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.80;TAMR=0.78;TASN=0.91;TAFR=0.79;TEUR=0.72;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3,DNase1;ENC=Histone,Open_Chromatin	GT:VR:RR:DP:GQ	1/1:19:0:19:.
1	1022037	.	C	T	1	low_snpqual;low_coverage	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,ENSG00000131591,NONE(dist=NONE),NONE(dist=NONE);UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs6701114;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.60;TAMR=0.65;TASN=0.77;TAFR=0.44;TEUR=0.56;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:5:0:5:.
1	1025301	.	T	C	59	PASS	AC=0;AF=0.000000;ReqIncl=.;PU=.;RFG=intronic;GI=C1orf159,NONE(dist=NONE),NONE(dist=NONE),ENSG00000131591;UCG=intronic;ENS=intronic;ENSGN=ENSG00000131591;MT=intergenic;MTGN=.;GN=C1orf159;RSID=rs9442400;CD=.;HT=.;HC=.;HD=.;HP=.;AV=.;AT=.;EV=.;ET=.;CG=.;IET=0;IEO=0;IEN=.;MS=1;TMAF=0.86;TAMR=0.88;TASN=0.74;TAFR=0.92;TEUR=0.91;SF=.;SD=.;SM=.;SX=.;CID=.;CGENE=.;CSTRAND=.;CCDS=.;CAA=.;CCNT=.;NA=.;NC=.;NE=.;NF=.;NG=.;NH=.;NI=.;NJ=.;NK=.;NL=.;NM=.;ENN=H3K36me3;ENC=Histone	GT:VR:RR:DP:GQ	1/1:10:0:10:.
